Skip to main content
Sana Biotechnology, Inc. logo

Sana Biotechnology, Inc. — Investor Relations & Filings

Ticker · SANA ISIN · US7995661045 US Manufacturing
Open in API
Filings indexed 363 across all filing types
Latest filing 2023-09-13 Regulatory Filings
Country US United States of America
Listing US SANA

About Sana Biotechnology, Inc.

https://sana.com/

Sana Biotechnology, Inc. is a company that develops engineered cells as medicines to address the underlying causes of disease. Its core strategy involves two primary platforms: in vivo therapies designed to repair and control genes within a patient's existing cells, and ex vivo therapies that replace missing or damaged cells with new, functional ones. The company utilizes proprietary technologies, such as engineered fusogen proteins, for the targeted delivery of therapeutics. Sana's pipeline is focused on advancing drug candidates for a range of diseases, including diabetes, B-cell cancers, and B-cell related autoimmune disorders.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC by Sana Biotechnology, Inc. It includes a Regulation FD Disclosure about a corporate presentation released at a healthcare conference. The document references the filing of an investigational new drug application and clinical data expectations but does not contain detailed financial statements or substantive financial data. The corporate presentation is furnished as an exhibit but the main document is a regulatory announcement of this event and presentation. The length is 5789 characters, which is relatively short and consistent with a regulatory announcement rather than a full report. The document explicitly states that the information furnished shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, indicating it is an announcement rather than a full report. Therefore, this filing is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2023-09-13 English
8-K
Regulatory Filings Classification · 100% confidence The document is a Form 8-K Current Report filed with the SEC, dated August 17, 2023, by Sana Biotechnology, Inc. It reports the termination of a material definitive agreement, specifically a lease termination agreement. The content focuses on a specific event related to the company's lease and does not contain financial statements or detailed financial performance data. It is a regulatory announcement of a material event rather than a full financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2023-08-21 English
10-Q
Interim / Quarterly Report Q2 2023
2023-08-03 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 3, 2023, by Sana Biotechnology, Inc. It announces the issuance of a press release containing financial results for the quarter and year ended June 30, 2023. The document explicitly states that the press release is attached as Exhibit 99.1 and that the information is being furnished and not filed, indicating this is an announcement of financial results rather than the full financial report itself. The document length is 3556 characters, which is relatively short and consistent with an announcement rather than a full earnings release or quarterly report. The key section is Item 2.02 Results of Operations and Financial Condition, which typically corresponds to earnings releases or financial results announcements. However, since the actual financial results are in the attached press release and this document is primarily an announcement of that release, it fits best under Earnings Release (ER). The document is not a full quarterly or annual report, nor is it a regulatory filing or certification. Therefore, the classification is Earnings Release (ER) with high confidence.
2023-08-03 English
PRIMARY DOCUMENT
Director's Dealing
2023-07-06 English
PRIMARY DOCUMENT
Director's Dealing
2023-07-06 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.